Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-21
DOI
10.1038/s41598-022-10008-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proton pump inhibitor use and the efficacy of chemotherapy in metastatic colorectal cancer: a post hoc analysis of a randomized phase 3 trial ( AXEPT )
- (2021) Sun Young Kim et al. ONCOLOGIST
- Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study
- (2020) Wei-Yi Lei et al. Clinics and Research in Hepatology and Gastroenterology
- Moving to a World Beyond “p
- (2019) Ronald L. Wasserstein et al. AMERICAN STATISTICIAN
- Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, and 5-fluorouracil
- (2019) Masae Sekido et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Concomitant use of capecitabine and proton pump inhibitors – Is it safe?
- (2019) Vian Cheng et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
- (2019) Yojiro Hashiguchi et al. International Journal of Clinical Oncology
- Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer
- (2019) Takayuki Yoshino et al. JAMA Oncology
- Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review
- (2019) D. Viñal et al. Clinical & Translational Oncology
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
- (2018) Grace G. Wong et al. Clinical Colorectal Cancer
- Evaluation of the clinical impact of concomitant acid suppression therapy in colorectal cancer patients treated with capecitabine monotherapy
- (2018) Hannah E Rhinehart et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer
- (2017) Michael P. Chu et al. JAMA Oncology
- The ASA's Statement onp-Values: Context, Process, and Purpose
- (2016) Ronald L. Wasserstein et al. AMERICAN STATISTICIAN
- Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients
- (2016) Julia Sun et al. Clinical Colorectal Cancer
- Is right-sided colon cancer different to left-sided colorectal cancer? – A systematic review
- (2015) G.H. Lee et al. EJSO
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
- (2015) Toshiaki Watanabe et al. International Journal of Clinical Oncology
- Sex- and gender-specific disparities in colorectal cancer risk
- (2015) Sung-Eun Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Local bacteria affect the efficacy of chemotherapeutic drugs
- (2015) Panos Lehouritis et al. Scientific Reports
- Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials
- (2014) Hans-Joachim Schmoll et al. LANCET ONCOLOGY
- Use of proton pump inhibitors correlates with increased risk of colorectal cancer in Taiwan
- (2013) Shih-Wei Lai et al. Asia-Pacific Journal of Clinical Oncology
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
- (2011) Toshiaki Watanabe et al. International Journal of Clinical Oncology
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Proton Pump Inhibitors and the Risk of Colorectal Cancer
- (2010) Shicai Chen et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
- (2009) Stanley Xu et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search